Novartis
NVS
NVS
986 hedge funds and large institutions have $19.3B invested in Novartis in 2018 Q2 according to their latest regulatory filings, with 65 funds opening new positions, 343 increasing their positions, 397 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
986
Holders Change
-25
Holders Change %
-2.47%
% of All Funds
22.6%
Holding in Top 10
13
Holding in Top 10 Change
-11
Holding in Top 10 Change %
-45.83%
% of All Funds
0.3%
New
65
Increased
343
Reduced
397
Closed
82
Calls
$96.7M
Puts
$26.8M
Net Calls
+$69.9M
Net Calls Change
+$29.6M
Top Buyers
| 1 |
CSIA
Charles Schwab Investment Advisory
San Francisco,
California
|
+$298M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
+$218M |
| 3 |
Renaissance Technologies
New York
|
+$137M |
| 4 |
D.E. Shaw & Co
New York
|
+$77.5M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$75.1M |
